Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway;
Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
Cancer Genomics Proteomics. 2022 Sep-Oct;19(5):576-583. doi: 10.21873/cgp.20342.
BACKGROUND/AIM: Aggressive angiomyxomas are mostly found in the pelvic and perineal region and are prone to recur after surgery. Cytogenetic information is available on only nine such tumors. Herein, we report the cytogenetic anomaly and its molecular consequence in another aggressive angiomyxoma.
An aggressive angiomyxoma found in a 33-year-old woman was examined using cytogenetic, RNA sequencing, reverse transcription polymerase chain reaction (RT-PCR), and Sanger sequencing techniques.
The karyotype of short-term cultured tumor cells was 46,XX,del(12) (q14q23)[9]/46,XX[2]. RNA sequencing detected fusion of the high mobility group AT-hook 2 gene (HMGA2) with the chromosome 12 open reading frame 42 gene (C12orf42). RT-PCR together with Sanger sequencing verified the presence of an HMGA2::C12orf42 fusion transcript.
The present case carrying del(12)(q14q23) and an HMGA2::C12orf42 chimeric transcript strengthens the notion that involvement of HMGA2 and its misexpression are pathogenetically important in the development of aggressive angiomyxomas.
背景/目的:侵袭性血管黏液瘤主要发生于骨盆和会阴区,术后易复发。目前仅有 9 例此类肿瘤的细胞遗传学信息。本文报道另一例侵袭性血管黏液瘤的细胞遗传学异常及其分子后果。
对一名 33 岁女性的侵袭性血管黏液瘤进行细胞遗传学、RNA 测序、逆转录聚合酶链反应(RT-PCR)和 Sanger 测序技术检测。
短期培养的肿瘤细胞的核型为 46,XX,del(12)(q14q23)[9]/46,XX[2]。RNA 测序检测到高迁移率族蛋白 AT 钩 2 基因(HMGA2)与染色体 12 开放阅读框 42 基因(C12orf42)融合。RT-PCR 结合 Sanger 测序证实存在 HMGA2::C12orf42 融合转录本。
本病例携带 del(12)(q14q23)和 HMGA2::C12orf42 嵌合转录本,进一步证实了 HMGA2 及其异常表达在侵袭性血管黏液瘤的发生发展中具有重要的发病机制意义。